PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 3.06M (Avg.)
-0.59 | -3.40
These metrics indicate whether the stock trades cheaply or expensively relative to its fundamentals. Value investors use them to find mispricings—buying stocks that appear undervalued, with solid long-term prospects and limited downside risk.
56.39
Positive P/E while Healthcare median is negative at -2.72. Peter Lynch would investigate competitive advantages in a distressed Healthcare.
53.30
P/S exceeding 1.5x Healthcare median of 11.96. Jim Chanos would check for potential multiple compression risks.
1.70
P/B 50-90% of Healthcare median of 3.11. Mohnish Pabrai would examine if this discount presents opportunity.
28092.70
Positive FCF while Healthcare median shows negative FCF. Peter Lynch would examine cash flow generation advantage.
1237.87
Positive operating cash flow while Healthcare median is negative. Peter Lynch would examine operational advantage.
1.70
Fair value ratio 50-90% of Healthcare median of 3.11. Mohnish Pabrai would examine if this gap presents opportunity.
0.44%
Positive earnings while Healthcare median shows losses. Peter Lynch would examine earnings quality advantage.
0.00%
Positive FCF while Healthcare median shows negative FCF. Peter Lynch would examine cash generation advantage.